RSS-Feed abonnieren
DOI: 10.1055/s-2007-969966
© Hippokrates Verlag Stuttgart
3,4-Dihydro-2, 2-Dimethyl-H-1 Benzopyran-6-Butyric Acid
Its Preparation from Zanthoxylol and its Antiinflammatory and Related Pharmacological PropertiesPublikationsverlauf
1981
1982
Publikationsdatum:
26. März 2007 (online)
![](https://www.thieme-connect.de/media/plantamedica/198302/lookinside/thumbnails/10.1055-s-2007-969966-1.jpg)
Abstract
Details of the preparation from zanthoxylol of a new anti-sickling agent, 3,4-dihydro-2,2-dimethyl-2-H-1 bezophyran-6-butyric acid, DBA, are given. The reaction involved converting zanthoxylol to its iodo-compound. This in turn was subsequently hydrolysed to DBA.
DBA dose-dependently inhibited carrageein-induced rat paw oedema. The ED50 was approximately 60 mg kg-1. Indomethacin and aspirin were similarly effective with ED50 of 2.2 and 91 mg kg-1 respectively. DBA also inhibited acetic acid induced squirming in mice. The ED50 was 58 mg kg-1 compared with 75 mg kg for aspirin. DBA, indomethacin and aspirin inhibited generation of prostaglandin-like activity by isolated segments of rabbit jejunum as well as the production of PG-like activity from arachidonic by cell-free homogenates of guinea-pig lung.
It is concluded that the mechanism of anti-inflammatory and analgesic activity of DBA, like that of aspirin and indomethacin, may involve inhibition of prostaglandin synthesis.
Key Word Index
Antiinflammatory - Analgesic, Inhibition of prostaglandin synthesis.